PFIZER INC PFE

Latest FY: 2025 Healthcare Drug Manufacturers - General
Market Price $26.79
Market Cap $152.75B
P/E Ratio 19.70
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-1.6% YoY
$62.58B
3-Yr CAGR: -14.6%
Net Income ↓-3.2% YoY
$7.77B
Net Margin: 12.4%
Free Cash Flow ↓-7.7% YoY
$9.07B
FCF Yield: 5.94%
EPS (Diluted) ↓-3.5% YoY
$1.36
Basic: $1.37
Return on Equity Efficiency
9.0%
ROA: 3.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (PFE)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $52,824.0M $40,495.0M $7,215.0M $1.11 $15,901.0M $14,078.0M
FY 2017 $52,546.0M -0.5% $41,306.0M $21,308.0M +195.3% $3.34 +200.9% $16,470.0M $14,514.0M +3.1%
FY 2018 $53,647.0M +2.1% $42,399.0M $11,153.0M -47.7% $1.77 -46.9% $15,827.0M $13,785.0M -5.0%
FY 2019 $51,750.0M -3.5% $41,531.0M $16,273.0M +45.9% $2.72 +53.5% $12,588.0M $10,412.0M -24.5%
FY 2020 $41,908.0M -19.0% $33,216.0M $9,616.0M -40.9% $1.71 -37.2% $14,403.0M $12,151.0M +16.7%
FY 2021 $81,288.0M +94.0% $50,467.0M $21,979.0M +128.6% $3.85 +125.1% $32,580.0M $29,869.0M +145.8%
FY 2022 $100,330.0M +23.4% $65,986.0M $31,372.0M +42.7% $5.47 +42.1% $29,267.0M $26,031.0M -12.8%
FY 2023 $50,914.0M -49.3% $25,960.0M $2,119.0M -93.2% $0.37 -93.2% $8,700.0M $4,793.0M -81.6%
FY 2024 $63,627.0M +25.0% $45,776.0M $8,031.0M +279.0% $1.41 +281.1% $12,744.0M $9,835.0M +105.2%
FY 2025 $62,579.0M -1.6% $46,512.0M $7,771.0M -3.2% $1.36 -3.5% $11,704.0M $9,075.0M -7.7%
$

Valuation

Market Price $26.79
Market Cap $152.75B
Enterprise Value $216.24B
P/E Ratio 19.70
P/B Ratio 1.77
FCF Yield 5.94%
Dividend Yield 6.42%
Shares Outstanding 5,699,444,200
%

Profitability & Margins

Gross Margin 74.33%
Operating Margin 10.74%
Net Margin 12.42%
Return on Equity (ROE) 8.99%
Return on Assets (ROA) 3.73%
Asset Turnover 0.30x
Revenue 3-Yr CAGR -14.56%
🛡️

Financial Health & Liquidity

Current Ratio 1.16
Cash Ratio 0.03
Debt / Equity 0.747
Debt / Assets 0.311
Cash & Equivalents $1.14B
Total Debt $64.64B
Book Value / Share $15.17
💧

Cash Flow Efficiency

Operating Cash Flow $11.70B
Capital Expenditures (CapEx) $2.63B
Free Cash Flow $9.07B
OCF / Revenue 18.70%
FCF / Revenue 14.50%
FCF 3-Yr CAGR -29.62%
🏷️

Per Share Metrics

EPS (Diluted) $1.36
EPS (Basic) $1.37
Dividends / Share $1.72
Book Value / Share $15.17
EPS YoY Growth -3.55%
🏛️

Balance Sheet (FY 2025)

Total Assets $208.16B
Total Liabilities $121.39B
Stockholders' Equity $86.48B
Current Assets $42.90B
Current Liabilities $36.98B